Ocaliva

Active Ingredient(s): Obeticholic Acid
FDA Approved: * May 27, 2016
Pharm Company: * INTERCEPT PHARMACEUTICALS INC

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ocaliva Overview

Obeticholic acid (abbreviated to OCA, trade name Ocaliva), is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid. It is used as a drug to treat primary biliary cholangitis, and is undergoing development for several other liver diseases and related disorders. Intercept Pharmaceuticals Inc. hold the worldwide rights to develop OCA outside Japan and China, where it is licensed to Dainippon Sumitomo Pharma.[2] Contents 1 I...

Read more Ocaliva Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Obeticholic_acid

Recent Ocaliva Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Ocaliva: (2 results)

Sorted by National Drug Code

• 69516-005 Ocaliva 5 mg Oral Tablet, Film Coated by Intercept Pharmaceuticals Inc
• 69516-010 Ocaliva 10 mg Oral Tablet, Film Coated by Intercept Pharmaceuticals Inc

Other drugs which contain Obeticholic Acid or a similar ingredient: (1 result)

• OBETICHOLIC ACID